DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy. (Q52913574)
Jump to navigation
Jump to search
scientific article published in January 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy. |
scientific article published in January 2009 |
Statements
DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy. (English)
1 reference
Oliver Hartmann
1 reference
Frédérique Spyratos
1 reference
Nadia Harbeck
1 reference
Dimo Dietrich
1 reference
Anne Fassbender
1 reference
Manfred Schmitt
1 reference
Serenella Eppenberger-Castori
1 reference
Vincent Vuaroqueaux
1 reference
Florence Lerebours
1 reference
Katrin Welzel
1 reference
Sabine Maier
1 reference
Achim Plum
1 reference
Stephan Niemann
1 reference
John A Foekens
1 reference
Ralf Lesche
1 reference
John W M Martens
1 reference
1 January 2009
1 reference
15
1 reference
1
1 reference
315-323
1 reference
Identifiers
1 reference